Affiliation:
1. School of Medicine Shahid Sadoughi University of Medical Sciences Yazd Iran
2. Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health Shahid Sadoughi University of Medical Sciences Yazd Iran
3. Department of Epidemiology, School of Public Health Iran University of Medical Sciences Tehran Iran
4. Department of Biostatistics and Epidemiology Shahid Sadoughi University of Medical Sciences Yazd Iran
5. Golestan Research Center of Gastroenterology and Hepatology Golestan University of Medical Sciences Gorgan Iran
6. Department of Public Health Torbat Jam Faculty of Medical Sciences Torbat Jam Iran
7. Diabetes Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran
Abstract
AbstractBackgroundCervical cancer is a common, and fatal cancer in women worldwide. This cancer is the fourth most common cancer in women after breast, colorectal, and lung cancer.AimsThis study aims to investigate the age‐standardized incidence rate (ASR) and the geographical distribution of Cervical Cancer in Iran.MethodsThis study was designed as a descriptive cross‐sectional investigation. The study sample comprised all individuals registered as cervical cancer patients in the National Cancer Registry system in 2016. The crude rate and ASR for each province were computed independently. Furthermore, we employed ArcMap10.5 software and geographic information system to conduct an analysis of the gathered data. In order to ascertain the spatial distribution and clustering of cervical cancer incidence, we utilized Moran's I, which measures spatial autocorrelation.ResultsWe studied a total of 808 cases of cervical cancer with a median age to be 52.19 years (IQR≈1.35). Among these cases, 685 (84.7%) were diagnosed based on the pathological reports with morphological verification, while 81 patients (10.1%) were clinically identified, and 42 cases (5.2%) were diagnosed using the death certificate‐only method. Squamous cell carcinoma accounted for 61% of all cases (n = 497). The ASR of cervical cancer in Iran was 1.90 per 100 000 populations. The provincial ASR ranged from 0.29 to 5.03 per 100 000, with the highest rates observed in Golestan (5.03), East Azerbaijan (4.07), and Ilam (3.72). We found no clustering patterns in the distribution of provincial crude, age‐specific, and age‐standardized incidence rates (p > .05).ConclusionThe incidence of cervical cancer in Iran was lower than the global average, and we did not identify any significant disparities in the incidence rates among the provinces. Although there were differences in incidence rates among the areas, these were not clustered. It is crucial to remember that cervical cancer is still a major public health issue in Iran, and in order to lessen the disease's burden, national initiatives to enhance screening, early identification, and access to efficient treatment should continue to be top priorities.